| In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in … M Grazia Revello, F Baldanti, E Percivalle, A Sarasini, L De-Giuli, ... Journal of General Virology 82 (6), 1429-1438, 2001 | 133 | 2001 |
| Vasculopathy and coagulopathy associated with SARS-CoV-2 infection N Labo, H Ohnuki, G Tosato Cells 9 (7), 1583, 2020 | 109 | 2020 |
| Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8. 1 ELISA and a newly developed recombinant LANA ELISA GL Mbisa, W Miley, CJ Gamache, WK Gillette, D Esposito, R Hopkins, ... Journal of immunological methods 356 (1-2), 39-46, 2010 | 78 | 2010 |
| Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome et al. Labo N, Miley W, Marshall V, Gillette W, Esposito PLoS Pathogens 10 (3), 2014 | 72 | 2014 |
| Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy N Labo, W Miley, CA Benson, TB Campbell, D Whitby Aids 29 (10), 1217-1225, 2015 | 62 | 2015 |
| T-cell responses to KSHV infection: a systematic approach R Roshan, N Labo, M Trivett, W Miley, V Marshall, L Coren, EMC Castro, ... Oncotarget 8 (65), 109402, 2017 | 51 | 2017 |
| HOPE in action: a prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV CM Durand, S Florman, JD Motter, D Brown, D Ostrander, S Yu, T Liang, ... American journal of transplantation 22 (3), 853-864, 2022 | 47 | 2022 |
| Kaposi sarcoma–associated herpesvirus in a rural Ugandan cohort, 1992–2008 R Newton, N Labo, K Wakeham, W Miley, G Asiki, WT Johnston, D Whitby The Journal of infectious diseases 217 (2), 263-269, 2018 | 45 | 2018 |
| Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon K Stolka, P Ndom, J Hemingway-Foday, J Iriondo-Perez, W Miley, N Labo, ... Cancer epidemiology 38 (2), 137-143, 2014 | 45 | 2014 |
| Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA M Gruffaz, T Zhang, V Marshall, P Gonçalves, R Ramaswami, N Labo, ... PLoS pathogens 16 (1), e1008114, 2020 | 44 | 2020 |
| Serodiagnosis for tumor viruses BJ Morrison, N Labo, WJ Miley, D Whitby Seminars in oncology 42 (2), 191-206, 2015 | 44 | 2015 |
| Mutual detection of Kaposi's sarcoma‐associated herpesvirus and Epstein–Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma N Labo, V Marshall, W Miley, E Davis, B McCann, KB Stolka, P Ndom, ... International Journal of Cancer 145 (9), 2468-2477, 2019 | 43 | 2019 |
| Sequence analysis of Kaposi sarcoma–associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome A Ray, V Marshall, T Uldrick, R Leighty, N Labo, K Wyvill, K Aleman, ... The Journal of infectious diseases 205 (11), 1665-1676, 2012 | 43 | 2012 |
| Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine F Baldanti, S Paolucci, G Maga, N Labo, U Hübscher, AY Skoblov, ... Aids 17 (10), 1568-1570, 2003 | 38 | 2003 |
| Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study V Marshall, E Martró, N Labo, A Ray, D Wang, G Mbisa, RK Bagni, ... The Journal of infectious diseases 202 (7), 1126-1135, 2010 | 37 | 2010 |
| Determinants of gammaherpesvirus shedding in saliva among Ugandan children and their mothers R Newton, N Labo, K Wakeham, V Marshall, R Roshan, A Nalwoga, ... The Journal of infectious diseases 218 (6), 892-900, 2018 | 36 | 2018 |
| Genome-wide sequence analysis of Kaposi sarcoma-associated herpesvirus shows diversification driven by recombination N Sallah, AL Palser, SJ Watson, N Labo, G Asiki, V Marshall, R Newton, ... The Journal of infectious diseases 218 (11), 1700-1710, 2018 | 33 | 2018 |
| Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections N Sallah, W Miley, N Labo, T Carstensen, S Fatumo, D Gurdasani, ... Nature Communications 11 (1), 3849, 2020 | 31 | 2020 |
| Relationship between anemia, malaria coinfection, and Kaposi sarcoma-associated herpesvirus seropositivity in a population-based study in rural Uganda A Nalwoga, S Cose, S Nash, W Miley, G Asiki, S Kusemererwa, ... The Journal of infectious diseases 218 (7), 1061-1065, 2018 | 28 | 2018 |
| Risk factors for Kaposi’s sarcoma–associated herpesvirus DNA in blood and in saliva in rural Uganda A Nalwoga, M Nakibuule, V Marshall, W Miley, N Labo, S Cose, D Whitby, ... Clinical Infectious Diseases 71 (4), 1055-1062, 2020 | 27 | 2020 |
Thomas S UldrickMedical Director, Regeneron; Associate Member, Fred Hutchinson Cancer InstitutePotvrđena adresa e-pošte na fredhutch.org
